It is speculated that highly suppressive FoxP3+Helios+ Tregs could play harmful roles in inhibiting anti-tumor immune responses in the circulation, especially at CRC advanced stages, while these cells could be beneficial in controlling inflammation in the TME especially at CRC early stages. Here, FOXP3 is linked to colorectal carcinoma.